etoro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Stocks-CRMD-CorMedix Inc

CorMedix Inc CRMD

‎$‎4.520.02(0.44%)(1D)
• Delayed prices by NASDAQ • in USD
Analyst Forecast
Consensus
Strong Buy
Price Target
13.67
Based on analysts who covered CRMD
Invest in CorMedix Inc
Today
Create an etoro account to buy CRMD stock on a secure, user-friendly, multi-asset trading platform.
CorMedix Inc CRMD
Buy CorMedix Inc

CRMD Stock Price Chart

‎-38.08‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered by
*Past performance is not an indication of future results
Asset negative trend

The CorMedix Inc share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The CorMedix Inc share price today is ‎$‎4.52, reflecting a ‎0.44‎% change over the last 24 hours and ‎-6.42‎% over the past week. The current market capitalization of CRMD is ‎$‎357.92M with an average volume in the last three months of 1.37M. The stock has a P/E ratio of 6.84 and a dividend yield of 0%. With the stock’s beta sitting at 1.07
CRMD Key Metrics
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎357.92M

Day’s Range
i
Shows the high and low prices of the day.
‎$‎4.51 - ‎$‎4.65

52W Range
i
Shows the high and low prices of the last year.
‎$‎4.48 - ‎$‎17.35

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
1.37M

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
6.84

Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎412.49M

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎4.5

EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎0.66

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.07

How can I buy CorMedix Inc stocks?

To purchase CorMedix Inc:
01

Create an etoro account:

Sign up for an etoro account and verify your identity.
02

Deposit funds:

Deposit funds into your etoro account using your preferred payment method.
03

Search and purchase:

Search the CorMedix Inc (CRMD) page and place an order to buy CorMedix Inc.
Looking for more information? Check out our guide on Academy.
What Is CorMedix Inc?
CorMedix Inc is a biopharmaceutical company aimed at harnessing its unique therapeutic technology to develop and commercialise products that prevent and treat infectious and inflammatory diseases. The company operates globally, with a significant presence across the US and Europe.

Operating in the healthcare sector, CorMedix Inc provides a range of pharmaceutical solutions with a primary focus on diseases caused by microbes such as bacteria, viruses and fungi. Unique to CorMedix Inc is its Neutrolin product, a non-antibiotic antimicrobial solution used in preventing catheter-related bloodstream infections and thrombosis.

Diversify your virtual portfolio by following CRMD shares on eToro.
CEO
Joseph Todisco, MBA
Employees
191
Founded
2006
HQ
Parsippany, New Jersey, US
Invest in CorMedix Inc
Today
Create an etoro account to buy CRMD stock on a secure, user-friendly, multi-asset trading platform.
Buy CorMedix Inc

FAQ

The current price of CRMD is ‎$‎4.52.
The average price target for CorMedix Inc is ‎$‎13.67. Sign up to etoro for detailed analyst forecasts and price targets.
Analysts offer forecasts for CorMedix Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of CorMedix Inc is ‎$‎357.92M
Based on 3 analysts offering recommendations for CRMD in the last 3 months, the overall consensus is Strong Buy.
Scroll to top